Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis

Shaista Malik, Yanglu Zhao, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Alain G. Bertoni, Nathan D. Wong

Research output: Contribution to journalArticle

Abstract

IMPORTANCE Although the risk of type 2 diabetes is considered to be equivalent to coronary heart disease (CHD) risk, there is considerable heterogeneity among individuals for CHD and atherosclerotic cardiovascular disease (ASCVD) risk. It is not known whether coronary artery calcium (CAC) assessment at baseline in individuals with established metabolic syndrome (MetS) or diabetes identifies CHD and ASCVD prognostic indicators during a long follow-up period. OBJECTIVE To compare improvement in long-term prognostication of incident CHD and ASCVD using CAC scores among those with diabetes, MetS, or neither condition. DESIGN, SETTING, AND PARTICIPANTS This study included participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective cohort study of 6814 males and females aged 45 to 84 years without known CVD from 4 race/ethnicity groups (white [38.5%], African American [27.5%], Hispanic [22.1%], and Chinese [11.9%]) recruited from 6 US communities from July 2000 through August 2002. Follow-up for each participant extended to the first occurrence of an incident event, other death, loss to follow-up, or the last follow-up call through December 31, 2013. Data analysis was performed from June 1, 2016, to September 12, 2017. Cox proportional hazards regression models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve and net reclassification improvement were used to compare incremental contributions of CAC score when added to the Framingham risk score, ethnicity/race, and socioeconomic status. MAIN OUTCOMES AND MEASURES CHD events, includingmyocardial infarction, resuscitated cardiac arrest, or CHD death. RESULTS Of 6814 MESA participants, 6751 had complete risk factor and follow-up data and were included in this study (mean [SD] age, 62.2 [10.2] years; 3186 [47.2%] male). A total of 881 (13.0%) had diabetes, 1738 (25.7%) had MetS, and 4132 (61.2%) had neither condition. After 11.1 mean years of follow-up, CHD events occurred in 84 participants with diabetes (135 ASCVD events), 115 with MetS (175 ASCVD events), and 157 with neither (250 ASCVD events). The CAC scorewas independently associated with incident CHD in multivariable analyses in those with diabetes (HR, 1.30; 95%CI, 1.19-1.43), MetS (HR, 1.30; 95%CI, 1.20-1.41), and neither condition (HR, 1.37; 95%CI, 1.27-1.47). For incident CHD, net reclassification improvement with addition of CAC scorewas 0.23 (95%CI, 0.10-0.37) in those with diabetes, 0.22 (95%CI, 0.09-0.35) in those with MetS, and 0.25 (95%CI, 0.15-0.35) in those with neither condition. The CAC score was also a prognostic indicator of CHD and ASCVD after controlling for diabetes duration of 10 years or longer at baseline, insulin use, and glycemic control. CONCLUSIONS AND RELEVANCE In a large multiethnic cohort, the addition of CAC score to global risk assessment was associated with significantly improved risk classification in those with MetS and diabetes, even if diabetes duration was longer than a decade, suggesting a role for the CAC score in risk assessment in such patients.

Original languageEnglish (US)
Pages (from-to)1332-1340
Number of pages9
JournalJAMA Cardiology
Volume2
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Type 2 Diabetes Mellitus
Coronary Disease
Atherosclerosis
Coronary Vessels
Calcium
Cardiovascular Diseases
Heart Arrest
Hispanic Americans
Proportional Hazards Models
Social Class
African Americans
Infarction
Cohort Studies
Outcome Assessment (Health Care)
Prospective Studies
Insulin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. / Malik, Shaista; Zhao, Yanglu; Budoff, Matthew; Nasir, Khurram; Blumenthal, Roger S; Bertoni, Alain G.; Wong, Nathan D.

In: JAMA Cardiology, Vol. 2, No. 12, 01.12.2017, p. 1332-1340.

Research output: Contribution to journalArticle

Malik, Shaista ; Zhao, Yanglu ; Budoff, Matthew ; Nasir, Khurram ; Blumenthal, Roger S ; Bertoni, Alain G. ; Wong, Nathan D. / Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. In: JAMA Cardiology. 2017 ; Vol. 2, No. 12. pp. 1332-1340.
@article{94af338dad5342fdb3c2bc1312ed16fb,
title = "Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis",
abstract = "IMPORTANCE Although the risk of type 2 diabetes is considered to be equivalent to coronary heart disease (CHD) risk, there is considerable heterogeneity among individuals for CHD and atherosclerotic cardiovascular disease (ASCVD) risk. It is not known whether coronary artery calcium (CAC) assessment at baseline in individuals with established metabolic syndrome (MetS) or diabetes identifies CHD and ASCVD prognostic indicators during a long follow-up period. OBJECTIVE To compare improvement in long-term prognostication of incident CHD and ASCVD using CAC scores among those with diabetes, MetS, or neither condition. DESIGN, SETTING, AND PARTICIPANTS This study included participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective cohort study of 6814 males and females aged 45 to 84 years without known CVD from 4 race/ethnicity groups (white [38.5{\%}], African American [27.5{\%}], Hispanic [22.1{\%}], and Chinese [11.9{\%}]) recruited from 6 US communities from July 2000 through August 2002. Follow-up for each participant extended to the first occurrence of an incident event, other death, loss to follow-up, or the last follow-up call through December 31, 2013. Data analysis was performed from June 1, 2016, to September 12, 2017. Cox proportional hazards regression models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve and net reclassification improvement were used to compare incremental contributions of CAC score when added to the Framingham risk score, ethnicity/race, and socioeconomic status. MAIN OUTCOMES AND MEASURES CHD events, includingmyocardial infarction, resuscitated cardiac arrest, or CHD death. RESULTS Of 6814 MESA participants, 6751 had complete risk factor and follow-up data and were included in this study (mean [SD] age, 62.2 [10.2] years; 3186 [47.2{\%}] male). A total of 881 (13.0{\%}) had diabetes, 1738 (25.7{\%}) had MetS, and 4132 (61.2{\%}) had neither condition. After 11.1 mean years of follow-up, CHD events occurred in 84 participants with diabetes (135 ASCVD events), 115 with MetS (175 ASCVD events), and 157 with neither (250 ASCVD events). The CAC scorewas independently associated with incident CHD in multivariable analyses in those with diabetes (HR, 1.30; 95{\%}CI, 1.19-1.43), MetS (HR, 1.30; 95{\%}CI, 1.20-1.41), and neither condition (HR, 1.37; 95{\%}CI, 1.27-1.47). For incident CHD, net reclassification improvement with addition of CAC scorewas 0.23 (95{\%}CI, 0.10-0.37) in those with diabetes, 0.22 (95{\%}CI, 0.09-0.35) in those with MetS, and 0.25 (95{\%}CI, 0.15-0.35) in those with neither condition. The CAC score was also a prognostic indicator of CHD and ASCVD after controlling for diabetes duration of 10 years or longer at baseline, insulin use, and glycemic control. CONCLUSIONS AND RELEVANCE In a large multiethnic cohort, the addition of CAC score to global risk assessment was associated with significantly improved risk classification in those with MetS and diabetes, even if diabetes duration was longer than a decade, suggesting a role for the CAC score in risk assessment in such patients.",
author = "Shaista Malik and Yanglu Zhao and Matthew Budoff and Khurram Nasir and Blumenthal, {Roger S} and Bertoni, {Alain G.} and Wong, {Nathan D.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1001/jamacardio.2017.4191",
language = "English (US)",
volume = "2",
pages = "1332--1340",
journal = "JAMA Cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis

AU - Malik, Shaista

AU - Zhao, Yanglu

AU - Budoff, Matthew

AU - Nasir, Khurram

AU - Blumenthal, Roger S

AU - Bertoni, Alain G.

AU - Wong, Nathan D.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - IMPORTANCE Although the risk of type 2 diabetes is considered to be equivalent to coronary heart disease (CHD) risk, there is considerable heterogeneity among individuals for CHD and atherosclerotic cardiovascular disease (ASCVD) risk. It is not known whether coronary artery calcium (CAC) assessment at baseline in individuals with established metabolic syndrome (MetS) or diabetes identifies CHD and ASCVD prognostic indicators during a long follow-up period. OBJECTIVE To compare improvement in long-term prognostication of incident CHD and ASCVD using CAC scores among those with diabetes, MetS, or neither condition. DESIGN, SETTING, AND PARTICIPANTS This study included participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective cohort study of 6814 males and females aged 45 to 84 years without known CVD from 4 race/ethnicity groups (white [38.5%], African American [27.5%], Hispanic [22.1%], and Chinese [11.9%]) recruited from 6 US communities from July 2000 through August 2002. Follow-up for each participant extended to the first occurrence of an incident event, other death, loss to follow-up, or the last follow-up call through December 31, 2013. Data analysis was performed from June 1, 2016, to September 12, 2017. Cox proportional hazards regression models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve and net reclassification improvement were used to compare incremental contributions of CAC score when added to the Framingham risk score, ethnicity/race, and socioeconomic status. MAIN OUTCOMES AND MEASURES CHD events, includingmyocardial infarction, resuscitated cardiac arrest, or CHD death. RESULTS Of 6814 MESA participants, 6751 had complete risk factor and follow-up data and were included in this study (mean [SD] age, 62.2 [10.2] years; 3186 [47.2%] male). A total of 881 (13.0%) had diabetes, 1738 (25.7%) had MetS, and 4132 (61.2%) had neither condition. After 11.1 mean years of follow-up, CHD events occurred in 84 participants with diabetes (135 ASCVD events), 115 with MetS (175 ASCVD events), and 157 with neither (250 ASCVD events). The CAC scorewas independently associated with incident CHD in multivariable analyses in those with diabetes (HR, 1.30; 95%CI, 1.19-1.43), MetS (HR, 1.30; 95%CI, 1.20-1.41), and neither condition (HR, 1.37; 95%CI, 1.27-1.47). For incident CHD, net reclassification improvement with addition of CAC scorewas 0.23 (95%CI, 0.10-0.37) in those with diabetes, 0.22 (95%CI, 0.09-0.35) in those with MetS, and 0.25 (95%CI, 0.15-0.35) in those with neither condition. The CAC score was also a prognostic indicator of CHD and ASCVD after controlling for diabetes duration of 10 years or longer at baseline, insulin use, and glycemic control. CONCLUSIONS AND RELEVANCE In a large multiethnic cohort, the addition of CAC score to global risk assessment was associated with significantly improved risk classification in those with MetS and diabetes, even if diabetes duration was longer than a decade, suggesting a role for the CAC score in risk assessment in such patients.

AB - IMPORTANCE Although the risk of type 2 diabetes is considered to be equivalent to coronary heart disease (CHD) risk, there is considerable heterogeneity among individuals for CHD and atherosclerotic cardiovascular disease (ASCVD) risk. It is not known whether coronary artery calcium (CAC) assessment at baseline in individuals with established metabolic syndrome (MetS) or diabetes identifies CHD and ASCVD prognostic indicators during a long follow-up period. OBJECTIVE To compare improvement in long-term prognostication of incident CHD and ASCVD using CAC scores among those with diabetes, MetS, or neither condition. DESIGN, SETTING, AND PARTICIPANTS This study included participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective cohort study of 6814 males and females aged 45 to 84 years without known CVD from 4 race/ethnicity groups (white [38.5%], African American [27.5%], Hispanic [22.1%], and Chinese [11.9%]) recruited from 6 US communities from July 2000 through August 2002. Follow-up for each participant extended to the first occurrence of an incident event, other death, loss to follow-up, or the last follow-up call through December 31, 2013. Data analysis was performed from June 1, 2016, to September 12, 2017. Cox proportional hazards regression models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve and net reclassification improvement were used to compare incremental contributions of CAC score when added to the Framingham risk score, ethnicity/race, and socioeconomic status. MAIN OUTCOMES AND MEASURES CHD events, includingmyocardial infarction, resuscitated cardiac arrest, or CHD death. RESULTS Of 6814 MESA participants, 6751 had complete risk factor and follow-up data and were included in this study (mean [SD] age, 62.2 [10.2] years; 3186 [47.2%] male). A total of 881 (13.0%) had diabetes, 1738 (25.7%) had MetS, and 4132 (61.2%) had neither condition. After 11.1 mean years of follow-up, CHD events occurred in 84 participants with diabetes (135 ASCVD events), 115 with MetS (175 ASCVD events), and 157 with neither (250 ASCVD events). The CAC scorewas independently associated with incident CHD in multivariable analyses in those with diabetes (HR, 1.30; 95%CI, 1.19-1.43), MetS (HR, 1.30; 95%CI, 1.20-1.41), and neither condition (HR, 1.37; 95%CI, 1.27-1.47). For incident CHD, net reclassification improvement with addition of CAC scorewas 0.23 (95%CI, 0.10-0.37) in those with diabetes, 0.22 (95%CI, 0.09-0.35) in those with MetS, and 0.25 (95%CI, 0.15-0.35) in those with neither condition. The CAC score was also a prognostic indicator of CHD and ASCVD after controlling for diabetes duration of 10 years or longer at baseline, insulin use, and glycemic control. CONCLUSIONS AND RELEVANCE In a large multiethnic cohort, the addition of CAC score to global risk assessment was associated with significantly improved risk classification in those with MetS and diabetes, even if diabetes duration was longer than a decade, suggesting a role for the CAC score in risk assessment in such patients.

UR - http://www.scopus.com/inward/record.url?scp=85040000105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040000105&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2017.4191

DO - 10.1001/jamacardio.2017.4191

M3 - Article

VL - 2

SP - 1332

EP - 1340

JO - JAMA Cardiology

JF - JAMA Cardiology

SN - 2380-6583

IS - 12

ER -